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Percutaneous coronary intervention (PCI) improves anginal chest pain in most, but
not all, treated patients. PCI is associated with unplanned readmission for angina and
non-specific chest pain within 30-days of index PCI. Patients with an index hospitali-
zation for PCI between January–November in each of the years 2010–2014 were
included from the United States Nationwide Readmissions Database. Of 2 723 455
included patients, the 30-day unplanned readmission rate was 7.2% (n = 196 581,
42.3% female). This included 9.8% (n = 19 183) with angina and 11.1% (n = 21 714)
with non-specific chest pain. The unplanned readmission group were younger (62.2
vs 65.1 years; P < 0.001), more likely to be females (41.0% vs 34.2%; P < 0.001), from
the lowest quartile of household income (32.9% vs 31.2%; P < 0.001), have higher
prevalence of cardiovascular risk factors or have index PCI performed for non-acute
coronary syndromes (ACS) (OR:3.46, 95%CI 3.39–3.54). Factors associated with
angina readmissions included female sex (OR:1.28, 95%CI 1.25–1.32), history of
ischemic heart disease (IHD) (OR:3.28, 95%CI 2.95–3.66), coronary artery bypass
grafts (OR:1.79, 95%CI 1.72–2.86), anaemia (OR:1.16, 95%CI 1.11–1.21), hyperten-
sion (OR:1.13, 95%CI 1.09, 1.17), and dyslipidemia (OR:1.10, 95%CI 1.06–1.14).
Non-specific chest pain compared with angina readmissions were younger (mean dif-
ference 1.25 years, 95% CI 0.99, 1.50), more likely to be females (RR:1.13, 95%CI
1.10, 1.15) and have undergone PCI for non-ACS (RR:2.17, 95%CI 2.13, 2.21). Indica-
tions for PCI other than ACS have a greater likelihood of readmission with angina or
non-specific chest pain at 30-days. Readmissions are more common in patients with
modifiable risk factors, previous history of IHD and anaemia.
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1 | INTRODUCTION
Percutaneous coronary intervention (PCI) is indicated for acute cor-
onary syndromes (ACS) or the relief of anginal symptoms secondary
to myocardial ischemia, in patients with obstructive coronary artery
disease (CAD). Around 3 million procedures are performed world-
wide every year. The results of recent randomized, controlled trials
of clinical strategies involving invasive management of CAD have
not provided evidence of clear benefits for coronary revasculariza-
tion over medical therapy in patients with chronic coronary syn-
dromes (CCS).1,2
In the ABSORB-4 trial, which compared clinical outcomes in
patients treated with either a bioresorbable scaffold or a 3rd genera-
tion drug eluting stent, the occurrence and time-course of angina
post-PCI was similar in both groups, occurring in 11% of subjects by
30 days and 22% of patients by 1-year.3 The clinical characteristics
associated with anginal chest pain at these time-points and experi-
ence in less-selected, real-world populations are uncertain.
Readmission within 30 days following PCI is not uncommon, with a
broad spectrum of etiologies and degrees of severity.4 Readmissions
are commonly secondary to cardiac-related disorders or PCI complica-
tions and it is reported that readmission is associated with a greater
risk of mortality.5-8
In this study, we accessed a large, national readmissions data-
base to investigate the proportion of patients re-admitted to hos-
pital with chest pain attributed to angina or non-specific chest
pain within 30 days after PCI for ACS or CCS and the associated
clinical characteristics. In addition, we evaluated the cost burden
of chest pain readmissions compared with readmissions due to
other causes.
2 | METHODS
In the United States, the Healthcare Cost and Utilization Project
(HCUP) Nationwide Readmissions Database (NRD) records, hospitaliza-
tion and readmission data for all hospitalized patients within 21 States
and is produced by the Agency for Healthcare Research and Quality.
This study utilized deidentified data collected and distributed by HCUP
and does not require consent from individual patients or an institutional
board review (IRB) approval. The distribution of included municipalities
is geographically diverse and represents 49.1% of all hospital inpatients,
including patients with and without insurance. Admissions are linked by
an individual identification number, which enables linkage between
admissions independent of readmission location.
Patients were included if they are 18 years or older and underwent
PCI at index admission (ICD-9 Procedure code: 00.66, 36.06, 36.07)
with discharge data from 2010 to 2014. Only the first admission with
PCI within a calendar year was considered. Cases were excluded if they
died during index admission, had duplicate data, were missing demo-
graphic or readmission data, or readmitted electively. Additionally,
patients admitted in December are excluded as they lack 30 days of
follow-up. Patients who were readmitted with a primary chest pain
diagnosis are defined by ICD-9 codes (Angina – ICD-9: 413.0, 413.1,
413.9; non-specific chest pain [NSCP] – ICD-9: 786.5, 786.51) and clinic
classification software codes (stable coronary artery disease including
angina – CCS: 101; Non-specific chest pain – CCS: 102; see Table A1).
Demographic, comorbidity at index admission and outcome data as well
as detail of inpatient stay was captured through a combination of NRD
coding, ICD-9 and Elixhauser comorbidity codes. Cost-to-charge ratios
were applied to total charges as recommended by HCUP in order to
provide an estimate of inpatient cost.
Included patients 
(n = 2,723,455) 
Readmitted at 30-days 
(n = 196,581) 
Readmitted at 30-days 
with angina 
(n = 19,183) 
•
Exclusions: 
Readmitted at 30-days 
with non-specific chest 




admission (n = 54,891)
December discharge











Not readmitted with chest 
pain controls 
(n = 2,682,557) 
PCI on index 
admission 
(n = 3,700,737)
F IGURE 1 Flow diagram
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The primary outcome of this analysis is 30-day readmission with
a primary diagnosis of chest pain post-PCI, and variables associated
with readmission. A sub-group analysis of the characteristics of
patients with a primary diagnosis of angina and non-specific chest
pain is also performed.
Statistical analysis was performed using IBM Statistics SPSS (ver-
sion 24.0). Weighting is performed using sample discharge weights.
Dichotomization of patients based on the presence or absence of
readmission within 30 days and subsequent descriptive statistics are
presented. Chi-square or Independent Student-T testing with 95%
two-tailed significance was utilized for comparing patient demo-
graphics. Multiple logistic regression analyses were performed to
evaluate the association between these variables and readmission
within 30-days with angina, non-specific chest pain and the combined
population readmitted with angina or non-specific chest pain. Further-
more, the relative risk (RR) of association with variables and
readmission within 30-days of angina versus non-specific chest pain is
also evaluated.
3 | RESULTS
Of 3 700 737 identified as undergoing PCI in the United States in the
years 2010–2014, 2 723 455 were included in the analysis. The
TABLE 1 Patient demographics and characteristics including co-morbidities at index admission
Variable
All patients









(n = 2 723 455) (n = 2 682 557) (n = 40 897) (n = 21 714) (n = 19 183)
Age in years (SE) 65.1 (0.01) 65.1 (0.01) 62.2 (0.07) 61.6 (0.09) 62.8 (0.10)
Female 934 574 34.3% 917 814 34.2% 16 760 41.0% 9448 43.5% 7312 38.1%
Length of stay in days (SE) 3.85 (0.00) 3.87 (0.00) 2.39 (0.01) 1.84 (0.01) 3.02 (0.03)
Cost of inpatient stay (SE) $19 937 (10.6) $20 133 (10.7) $7083 (48.7) $5064 (24.7) $9368 (97.3)
Quartile of median
household income
0-25th 850 333 31.2% 836 868 31.2% 13 465 32.9% 7030 32.4% 6435 33.5%
26th-50th 721 854 26.5% 711 178 26.5% 10 677 26.1% 5700 26.3% 4977 25.9%
51st-75th 632 303 23.2% 622 988 23.2% 9315 22.8% 5098 23.5% 4217 22.0%
76th-100th 518 964 19.1% 511 523 19.1% 7441 18.2% 3886 17.9% 3555 18.5%
Smoker 1 106 460 40.6% 1 091 323 40.7% 15 138 37.0% 7875 36.3% 7263 37.9%
Obesity 421 971 15.5% 416 402 15.5% 5569 13.6% 2917 13.4% 2652 13.8%
Chronic renal failure 407 294 15.0% 401 715 15.0% 5579 13.6% 2738 12.6% 2841 14.8%
Family history of IHD 296 638 10.9% 293 374 10.9% 3264 8.0% 1619 7.5% 1645 8.6%
Personal history of IHD 2 565 060 94.2% 2 526 131 94.2% 38 930 95.2% 20 086 92.5% 18 844 98.2%
Previous MI 457 335 16.8% 447 478 16.7% 9856 24.1% 5233 24.1% 4623 24.1%
Dyslipidemia 1 915 626 70.3% 1 886 214 70.3% 29 412 71.9% 15 301 70.5% 14 111 73.6%
Hypertension 2 032 126 74.6% 2 000 647 74.6% 31 479 77.0% 16 586 76.4% 14 893 77.6%
Diabetes mellitus 1 027 612 37.7% 1 011 495 37.7% 16 118 39.4% 8490 39.1% 7628 39.8%
Heart failure 101 593 3.7% 101 241 3.8% 353 0.9% 76 0.4% 277 1.4%
Valvular heart disease 30 923 1.1% 30 815 1.1% 108 0.3% 18 0.1% 90 0.5%
History of stroke/TIA 161 953 5.9% 159 305 5.9% 2648 6.5% 1451 6.7% 1197 6.2%
Peripheral vascular disease 316 558 11.6% 312 850 11.7% 3708 9.1% 1702 7.8% 2006 10.5%
Anaemia 345 133 12.7% 340 076 12.7% 5058 12.4% 2424 11.2% 2634 13.7%
Atrial fibrillation 349 320 12.8% 345 303 12.9% 4017 9.8% 1799 8.3% 2218 11.6%
Previous CABG 251 465 9.2% 245 327 9.1% 6138 15.0% 3113 14.3% 3025 15.8%
Non-ACS index PCI 913 026 33.5% 887 497 33.1% 25 529 62.4% 17 208 79.2% 8321 43.4%
ACS index PCI 1 810 429 66.5% 1 795 059 66.9% 15 369 37.6% 4506 20.8% 10 863 56.6%
STEMI 565 264 20.8% 561 394 20.9% 3869 9.5% 1733 8.0% 2136 11.1%
NSTEMI/Unstable angina 1 261 856 46.3% 1 249 663 46.6% 12 193 29.8% 2791 12.9% 9402 49.0%
Abbreviations: ACS, acute coronary syndromes; CABG, coronary artery bypass grafts; IHD, ischemic heart disease; NSCP, non-specific chest pain; PCI,
percutaneous coronary intervention.
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reasons for exclusion are described in Figure 1. Of note, 326 759
were excluded due to a December discharge date. In total, 104 696
patients were excluded from analysis due to missing demographic, dis-
charge or mortality data.
3.1 | Characteristics of patients readmitted for
chest pain or angina within 30-days post-PCI
Within this post-PCI cohort (n = 2 723 455), 196 581 (7.2%) had an
unplanned hospital readmission for any cause within 30-days. Of
these, 40 897 (20.8%) patients (1.5% of the whole post-PCI cohort)
were readmitted with a primary diagnosis of chest pain at 30 days,
including 19 183 patients with angina and 21 714 with non-specific
chest pain. The demographics and medical history of the patients who
were or were not readmitted during a 30-day period are provided
within Table 1. Peak readmissions for chest pain, angina and non-
specific chest pain are observed within the first 48 h following dis-
charge post-PCI (Figure 2).
Multiple logistic regression models were created to examine the
associations between clinical characteristics and co-morbidities and
the likelihood of readmission with a primary diagnosis of angina or
non-specific chest pain at 30 days after PCI. We found several charac-
teristics that were strongly associated with readmission with chest
F IGURE 2 Distribution of readmissions with angina (A), non-specific chest pain (B), all chest pain (C), all-causes of readmission (D) within
30-days (X axis: days to readmission; Y axis: frequency)
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pain at 30-days (Table 2). The unplanned readmission group were
younger (62.2 vs 65.1 years; P < 0.001), more likely to be females
(41.0% vs 34.2%; P < 0.001) and within the lowest quartile of house-
hold income (32.9% vs 31.2%; P < 0.001). The readmission group also
had a higher prevalence of previous ischemic heart disease (IHD), cor-
onary artery bypass grafts (CABG), hypertension and dyslipidemia.
Furthermore, they were more likely to have index PCI performed for
non-ACS (odds ratio [OR]: 3.46, 95% CI 3.39, 3.54) (Supplementary
Figure 1).
3.2 | Characteristics of patients readmitted for
angina within 30-days post-PCI
Patients readmitted with angina within 30-days were more likely to
be female (OR: 1.28, 95% CI 1.25, 1.32), younger (OR: 0.98, 95% CI
0.98, 0.98), associate with the 0–25% of median household income
(OR: 1.06, 95% CI 1.02, 1.11), have history of IHD including previous
myocardial infarction (OR: 1.44, 95% CI 1.39, 1.49) or coronary artery
bypass grafting (OR: 1.79 95% CI 1.72, 1.86, dyslipidemia (OR: 1.10,
95% CI 1.02, 1.14), hypertension (OR: 1.13, 95% CI 1.09, 1.17) and
anaemia (OR: 1.16, 95% CI 1.11, 1.21). These patients were also more
likely to have undergone index PCI for indications other than ACS
(OR: 1.49, 95% CI 1.45, 1.54). Smoking status at index admission, obe-
sity, association with 76–100% of median household income, history
of heart failure, valvular heart disease, peripheral vascular disease, and
acute coronary syndrome on index PCI (OR = 0.67, 95% CI 0.65, 0.69)
were less likely to be observed compared with those who were not
readmitted within 30-days (Figure 3).
3.3 | Characteristics of patients readmitted for
non-specific chest pain within 30-days post-PCI
Of those readmitted with non-specific chest pain within 30-days,
female gender (OR: 1.57, 95% CI 1.53, 1.62), younger age (OR: 0.97,
95% CI 0.97, 0.97), association with 51–75% of household income
(OR: 1.05, 95% CI 1.01, 1.10), previous history of coronary artery
TABLE 2 Demographic and clinical characteristics associated with the likelihood of readmission at 30-days with chest pain following PCI
Variable
All chest pain NSCP Angina
(n = 40 897) (n = 21 714) (n = 19 183)
Odds Ratio (95% C.I.) P value Odds Ratio (95% C.I.) P value Odds Ratio (95% C.I.) P value
Female 1.44 (1.41, 1.47) <0.0005 1.57 (1.53, 1.62) <0.0005 1.28 (1.25, 1.32) <0.0005
Age 0.97 (0.97, 0.97) <0.0005 0.97 (0.97, 0.97) <0.0005 0.98 (0.98, 0.98) <0.0005
Smoker 0.87 (0.85, 0.89) <0.0005 0.91 (0.89, 0.94) <0.0005 0.84 (0.81, 0.86) <0.0005
Obesity 0.78 (0.76, 0.80) <0.0005 0.79 (0.76, 0.82) <0.0005 0.78 (0.75, 0.81) <0.0005
Q1 (0-25th %) 1.04 (1.01, 1.07) 0.02 1.01 (0.97, 1.05) 0.57 1.06 (1.02, 1.11) 0.006
Q2 (26-50th %) 1.00 (0.97, 1.04( 0.787 1.02 (0.98, 1.06) 0.41 0.99 (0.95, 1.03) 0.653
Q3 (51-75th %) 1.01 (0.98, 1.04) 0.746 1.05 (1.01, 1.10) 0.024 0.96 (0.92, 1.00) 0.06
Q4 (76-100th %) 0.97 (0.94, 0.99) 0.02 0.99 (0.95, 1.03) 0.572 0.94 (0.91, 0.98) 0.006
Chronic kidney disease 0.94 (0.91, 0.97) <0.0005 0.88 (0.84, 0.92) <0.0005 1.00 (0.96, 1.04) 0.916
Family history of IHD 0.74 (0.71, 0.76) <0.0005 0.74 (0.70, 0.78) <0.0005 0.74 (0.71, 0.78) <0.0005
Personal history of IHD 1.20 (1.15, 1.26) <0.0005 0.76 (0.70, 0.78) <0.0005 3.28 (2.95, 3.66) <0.0005
Previous MI 1.36 (1.33, 1.39) <0.0005 1.28 (1.24, 1.32) <0.0005 1.44 (1.39, 1.49) <0.0005
Dyslipidemia 1.08 (1.06, 1.11) <0.0005 1.07 (1.04, 1.10) <0.0005 1.10 (1.06, 1.14) <0.0005
Hypertension 1.12 (1.09, 1.15) <0.0005 1.11 (1.07, 1.14) <0.0005 1.13 (1.09, 1.17) <0.0005
Diabetes Mellitus 0.97 (0.95, 0.99) 0.009 0.96 (0.93, 0.98) 0.002 0.99 (0.96, 1.02) 0.624
Heart Failure 0.18 (0.17, 0.20) <0.0005 0.07 (0.05, 0.08) <0.0005 0.36 (0.32, 0.41) <0.0005
Valvular Heart Disease 0.28 (0.23, 0.34) <0.0005 0.09 (0.06, 0.14) <0.0005 0.53 (0.43, 0.65) <0.0005
History of Stroke/TIA 1.11 (1.07, 1.16) <0.0005 1.18 (1.11, 1.24) <0.0005 1.03 (0.97, 1.10) 0.289
Peripheral Vascular Disease 0.76 (0.73, 0.78) <0.0005 0.65 (0.62, 0.68) <0.0005 0.88 (0.84, 0.92) <0.0005
Anaemia 1.04 (1.01, 1.08) 0.009 0.94 (0.89, 0.98) 0.003 1.16 (1.11, 1.21) <0.0005
Atrial Fibrillation 0.84 (0.82, 0.87) <0.0005 0.70 (0.66, 0.73) <0.0005 1.01 (0.97, 1.06) 0.663
Previous CABG 1.67 (1.63, 1.72) <0.0005 1.54 (1.49, 1.61) <0.0005 1.79 (1.72, 1.86) <0.0005
Non-ACS PCI on index adm. 3.46 (3.39, 3.54) <0.0005 8.26 (7.99, 8.54) <0.0005 1.49 (1.45, 1.54) <0.0005
ACS PCI on index admission 0.29 (0.28, 0.30) <0.0005 0.12 (0.12, 0.13) <0.0005 0.67 (0.65, 0.69) <0.0005
Abbreviations: ACS, acute coronary syndromes; CABG, coronary artery bypass grafts; IHD, ischemic heart disease; NSCP, non-specific chest pain; PCI,
percutaneous coronary intervention.
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bypass grafting (OR: 1.54, 95% CI 1.49, 1.61), myocardial infarction
(OR: 1.28, 95% CI 1.24, 1.32), hypertension (OR: 1.11, 95% CI 1.07,
1.14), dyslipidemia (OR: 1.07, 95% CI 1.04, 1.10), and history of cere-
brovascular events (OR: 1.18, 95% CI 1.11, 1.24) are more likely char-
acteristics compared with patients who were not readmitted. Patients
who underwent PCI for indications other than ACS at index admission
were observed to have a greater likelihood of readmission at 30-days
(OR: 8.26, 95% CI 7.99, 8.54). Reduced likelihood is observed in those
with a history of smoking, obesity, chronic kidney disease (stage 1–3),
family or personal history of IHD, diabetes mellitus, atrial fibrillation,
anaemia, peripheral vascular disease and valvular heart disease or his-
tory of heart failure prior to index PCI (Supplementary Figure 2).
3.4 | Comparisons of patients readmitted with
angina versus non-specific chest pain
Compared with patients readmitted within 30 days for nonspecific
chest pain, patients who were readmitted with a diagnosis of angina
within 30 days were older, more likely to be male, to associate with
the 0–25% of household income, have a smoking history, family or
personal history of IHD, chronic kidney disease (stage 1–3), dys-
lipidemia, history of heart failure or valvular heart disease, peripheral
vascular disease, anaemia, atrial fibrillation, previous CABG and acute
coronary syndrome on admission for index PCI (Supplementary
Table 3). Patients with angina readmissions within 30-days had a
higher inpatient mortality rate (Supplementary Table 1). Total charges
were greater in those readmitted with angina with longer average
duration of admission compared with non-specific chest pain.
3.5 | Duration of admission and costs
Patients readmitted with angina or non-specific chest pain had a
shorter duration of readmission hospital stay (mean: 2.3, 95% CI 2.37,
2.42) compared with those readmitted for other causes within a
30-day period (mean: 5.18 days, 95% CI 5.16, 1.21) (P < 0.005).
Angina or non-specific chest pain readmissions were also associated
with lower hospitalization costs ($7083) compared with other causes
of readmission ($11 642) (P < 0.005) (Supplementary Table 2).
4 | DISCUSSION
We have assessed unplanned readmission with a primary diagnosis of
angina or non-specific chest pain within 30-days of PCI in a large,
national database. We have found that early readmission with angina
or non-specific chest pain after PCI is uncommon. Only 1.5% of
F IGURE 3 Demographic and clinical characteristics associated with the likelihood of readmission at 30-days with angina following PCI. PCI,
Percutaneous coronary intervention
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patients treated with PCI were readmitted with angina or non-specific
chest pain and affected patients had more cardiovascular risk factors
and history of previous IHD. Nonetheless, since many patients
undergo PCI, a readmission rate of 1–2% within 30 days equates to a
considerable number of patients. Readmission after PCI was associ-
ated with an appreciable cost. Mortality during readmission is low in
keeping with the coded diagnoses.
4.1 | Causes of angina post-PCI
PCI is indicated for patients with anginal symptoms despite guideline-
directed medical therapy to relieve symptoms of angina and may
improve prognosis.9,10 However, although PCI is routinely successful,
angina may persist.11 The causes of persisting or recurrent angina
include incomplete revascularization, complications of PCI for exam-
ple, side-branch loss, or unusually, unsuccessful PCI. A further issue
may be the underutilization of available secondary preventative ther-
apy combinations, which may prevent the requirement to progress to
invasive management in chronic coronary syndromes.12 An under-
recognized problem is ischemia and no obstructive coronary artery
disease (INOCA). This group of disorders includes microvascular
angina, vasospastic angina or mixed microvascular/vasospastic angina,
in the absence of obstructive (≥50% diameter stenosis) or flow-
limiting (fractional flow reserve ≤0.80; non-hyperemic pressure
ratio ≤ 0.89) CAD.13 Patients with INOCA have a burden of anginal
symptoms and typically poorer quality of life compared to patients
with obstructive CAD.14 Microvascular angina may be associated with
obstructive CAD (Type 3 microvascular angina), or, alternatively, CAD
may be falsely classified as obstructive when in fact the primary cause
of angina is microvascular disease. Our analysis does not provide
information on the etiology of the chest pain in this cohort out with
diagnosis code however, it is observed that index acute coronary syn-
drome was significantly less common in angina and non-specific chest
pain readmissions at 30-days compared with index population within
this cohort. A limitation to this estimate is that readmissions from
recurrent myocardial infarction are more likely to occur within an
acute coronary syndrome subset rather than readmission with non-
specific or angina pain. Furthermore, identification of culprit arteries
may be less clear in patients undergoing PCI for non-ACS indications
so as not, to provide symptomatic benefit for patients with angina,
and therefore cause proportionately more readmissions. Further stud-
ies to investigate etiology within patients readmitted with chest pain
including the success of revascularization, residual coronary disease
burden and discharge medication are warranted.
Chest pain after PCI may be experienced in 36% to 42% of
patients undergoing both elective and emergent PCI.15-17 It is most
commonly described in the first 24 h following PCI but is described as
occurring within the first 3 weeks.16 In addition to non-cardiac causes
it is important to distinguish patients with benign chest pain from crit-
ical chest pain after PCI due to acute stent thrombosis, incomplete
revascularization, or disease progression affecting alternative coro-
nary regions. However, risk stratification in these patients is
challenging and may be influenced by the presence of persistently ele-
vated cardiac enzymes or electrocardiograph evolution in the absence
of new myocardial injury.18-20 Benign chest pain and patients with
stable angina post-PCI pain in the absence of ACS, pulmonary or
upper gastrointestinal pathologies is therefore understandably
recorded in up to one third of overall PCI re-admissions.21,22 No stan-
dard nomenclature for the clinical phenomenon of chest pain post-
PCI currently exists due to differing opinions of etiology and there are
no guidelines for a standardized approach to management.23
A further entity may include the psychological burden associated
with a diagnosis of non-specific chest pain and it is estimated that
anxiety disorders are prevalent in 30–50% of these patients.24 Soma-
tization disorders with chest pain symptoms may influence
readmission, particularly in non-ACS PCI indications.
4.2 | Healthcare implications of hospital
readmission post-PCI
Readmissions are a significant source of burden both on the patient
and the healthcare system, which is often used as a proxy-marker for
quality of care and penalty systems are implemented for providers
with greater proportions of readmission.25
Patients with chest pain constitute between 0.6 to 2.4% of
unplanned presentations to emergency departments and up to one in
four admissions to medical and cardiology wards.26-29 In the United
Kingdom, this represents a significant burden with non-ACS chest
pain equating to an average of 15.8 and 16.8 bed days per 1000 pop-
ulation for angina and non-specific chest pain respectively with
standalone 30-day mortalities of 1.5% and 0.7%.28 The incidence and
demographical distribution of patients readmitted with chest pain syn-
dromes has not previously been explored. Therefore, the burden on
health services as well as mortality and major adverse cardiac event
(MACE) rate for patients readmitted with chest pain post-PCI is not
clearly defined.
Our study involved a large sample that is likely to be reasonably
representative of the US population undergoing PCI. The NRD has
been utilized previously in patients with chest pain, which provides
precedent for selection in this study.30 Local audit and assessment of
chest pain readmissions should be encouraged in order to establish
local requirement for interventions, which may reduce readmissions
with non-specific chest pain and angina following PCI. This would
ensure appropriate utilization of available resources and financial
investment dependent on the localized burden of readmissions.
4.3 | Associations with cardiovascular risk factors:
implications for risk stratification
Demographic factors associated with higher likelihood of unplanned
readmission in this sample are in keeping with known cardiovascular
risk factors. However, smoking in this sample was not associated with
increased readmission at 30 days. This is based on index smoking
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status and it is plausible that this may be subject to the smoking modi-
fication and cessation programmes, which are commonplace in the
management of patients with coronary disease. Patients with heart
failure, valvular heart disease and non-cardiac vascular disease were
observed to be less likely to be re-admitted at 30-days. This is in part
due to the proportion undergoing PCI for ACS in whom ventricular
dysfunction if present will be identified following PCI rather than as a
co-morbidity on index admission and may also be secondary to
increased involvement of secondary care outpatient services in their
management and treatment planning.
Optimization of modifiable risk factors prior to intervention is
performed in surgical patients and the pre-operative assessment is
commonplace in order to improve surgical morbidity and mortal-
ity.31,32 However, currently there are no similar formalized pathways
for patients undergoing PCI which could be implemented in elective
angiography patients to improve long-term outcomes. Median house-
hold income was significantly associated with increased likelihood of
readmission at 30-days in patients with angina and those associating
with the 76–100% had a lower likelihood of readmission with a pri-
mary diagnosis of angina. Chronic kidney disease in this population
was not associated with increased likelihood of re-admission however,
the majority of patients included are of mild impairment as would be
expected to undergo PCI with contrast. Female gender was more
likely for patients readmitted within 30-days with angina and non-
specific chest pain and it is previously observed that microvascular
and vasospastic angina with INOCA or obstructive CAD is more com-
mon in female patients.33 Male gender was observed in the majority
of all groups in keeping with gender as a known risk factor of cardio-
vascular disease. Anaemia in this dataset is associated with increased
readmission with a primary diagnosis of angina at 30-days following
PCI. Although discharge haemoglobin concentrations are not provided
in the database, this may provide an area of potential modification for
patients prior to being discharged following PCI.
One evidence-based example of an intervention to reduce
readmissions following PCI is a multimodal strategy as described by
Tanguturi et al (2016).34 This involved a risk assessment of
readmission with the production of patient videos regarding subse-
quent chest pain or symptoms of heart failure. In addition, a formal
clinic review with a cardiology fellow and a computerized alert system
for re-presentations facilitated early cardiologist review. This package
of interventions reduced 30-day hospital readmission from 9.6% to
5.3% over the 4-year study period.
4.4 | Limitations
Limitations included the composition of the database from separate
yearly data, which prevents multi-year follow-up of these patients and
excludes those admitted in December from 30-day follow-up. On the
other hand, a longer follow-up period for example at 6 months would
necessitate the exclusion of the inverse proportion for that year and
would have reduced the external validity of the analysis. The database
is comprised of inpatient admissions and does not include discharges
from emergency care, community data or patients managed in obser-
vation areas following PCI. In the United States approximately 7.6 mil-
lion patients present with chest pain per annum, four out of five will
not require admission. A further limitation is the lack of information
on completeness of revascularization for included patients or their
prescribed medications at the time of discharge. This would be of
value in this cohort, particularly where subsequent angina diagnoses
are coded on readmission in patients who have undergone PCI for
indications other than ACS.
5 | CONCLUSIONS
Our study provides insights into the prevalence, risk factors and
health burden of readmission with angina or non-specific chest pain
following PCI. Secondary prevention measures to reduce cardiovascu-
lar risk such as correction of anaemia may help to optimize the clinical
status of patients prior to undergoing PCI. PCI performed for an indi-
cation other than ACS is associated with a greater likelihood of
readmission with angina or non-specific chest pain at 30-days within
this cohort and further investigation of the etiology within these
patients is required.
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APPENDIX
TABLE A1 Classification of clinic classification software codes for readmissions causes
Causes of readmission CCS code Diagnosis
Respiratory 127 Chronic obstructive pulmonary disease and bronchiectasis
128 Asthma
130 Pleurisy, pneumothorax, pulmonary collapse
131 Respiratory failure, insufficiency and arrest
132 Lung disease due to external agents
133 Other lower respiratory disease
134 Other upper respiratory disease









9 Sexually transmitted infection
76 Meningitis
77 Encephalitis
78 Other CNS infection and poliomyelitis
90 Inflammation or infection of eye
122 Pneumonia
123 Influenza
124 Acute and chronic tonsillitis
125 Acute bronchitis
126 Other upper respiratory infections
129 Aspiration pneumonitis
135 Intestinal infection
197 Skin and subcutaneous tissue infections
201 Infective arthritis and osteomyelitis (except that caused by tuberculosis
or sexually transmitted disease)
Bleeding 60 Acute posthaemorrhagic anaemia
153 Gastrointestinal haemorrhage
182 Haemorrhage during pregnancy; abrutio placenta; placenta previa
Peripheral vascular disease 114 Peripheral and visceral atherosclerosis
115 Aortic, peripheral and visceral artery aneurysms
116 Aortic and peripheral arterial embolism or thrombosis
117 Other circulatory disease
118 Phlebitis, thrombophlebitis and thromboembolism
119 Varicose veins of lower extremities
Genitourinary 159 Urinary tract infection
160 Calculus of the urinary tract
161 Other diseases of kidney and ureters
162 Other diseases of bladder and urethra
163 Genitourinary symptoms and ill-defined conditions
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TABLE A1 (Continued)
Causes of readmission CCS code Diagnosis
164 Hyperplasia of prostate
165 Inflammatory conditions of the male genital organs
166 Other male genital disorders
170 Prolapse of female genital organs
175 Other female genital disorders
215 Genitourinary congenital anomalies
Renal disease 156 Nephritis; nephrosis; renal sclerosis
157 Acute and unspecified renal failure
158 Chronic kidney disease
Gastrointestinal 138 Esophageal disorders
139 Gastroduodenal ulcer (except haemorrhage)
140 Gastritis and duodenitis
141 Other disorders of stomach and duodenum
142 Appendicitis and other appendiceal conditions
143 Abdominal hernia
144 Regional enteritis and ulcerative colitis
145 Intestinal obstruction without hernia
146 Diverticulosis and diverticulitis
147 Anal and rectal conditions
148 Peritonitis and intestinal abscess
149 Biliary tract disease
150 Liver disease; alcohol-related
151 Other liver diseases
152 Pancreatic disorders (not diabetes)
154 Noninfectious gastroenteritis
155 Other gastrointestinal disorders
214 Digestive congenital anomalies
222 Haemolytic jaundice and perinatal jaundice
250 Nausea and vomiting
251 Abdominal pain
TIA/stroke 109 Acute cerebrovascular disease
110 Occlusion of stenosis of precerebral arteries
111 Other and ill-defined cerebrovascular disease
112 Transient cerebral ischemia
113 Late effects of cerebrovascular disease
Trauma 207 Pathological fracture
225 Joint disorders and dislocations; trauma-related
226 Fracture of neck of femur (hip)
227 Spinal cord injury
228 Skull and face fractures
229 Fracture of upper limb
230 Fracture of lower limb
231 Other fractures
232 Sprains and strains
233 Intracranial injury
234 Crushing injury or internal injury
(Continues)
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TABLE A1 (Continued)
Causes of readmission CCS code Diagnosis
235 Open wounds of head; neck; and trunk
236 Open wounds of extremities
239 Superficial injury; contusion
244 Other injuries and conditions due to external causes
260 All (external causes of injury and poisoning)
Endocrine/metabolic 48 Thyroid disorders
49 Diabetes mellitus without complication
50 Diabetes mellitus with complication
51 Other endocrine disorders
53 Disorders of lipid metabolism
58 Other nutritional and endocrine/metabolic disorders
186 Diabetes or abnormal glucose tolerance complicating pregnancy;
childbirth; or the puerperium
Neuropsychiatric 650 Adjustment disorders
651 Anxiety disorders
652 Attention-deficit, conduct, and disruptive behavior disorders
653 Delirium, dementia, and amnestic and other cognitive disorders
654 Developmental disorders
655 Disorders usually diagnosed in infancy and childhood or adolescence
656 Impulse control disorders, NEC
657 Mood disorders
658 Personality disorders
659 Schizophrenia and other psychotic disorders
660 Alcohol-related disorders
661 Substance-related disorders
662 Suicide and intentional self-inflicted injury
663 Screening and history of mental health and substance abuse codes
670 Miscellaneous mental health disorders
79 Parkinson's disease
80 Multiple sclerosis
81 Other hereditary and degenerative nervous system conditions
82 Paralysis
83 Epilepsy, convulsions
84 Headache including migraine
85 Coma, stupor and brain damage
95 Other nervous system disorders
216 Nervous system congenital anomalies
650 Adjustment disorders
651 Anxiety disorders
652 Attention-deficit, conduct, and disruptive behavior disorders
653 Delirium, dementia, and amnestic and other cognitive disorders
654 Developmental disorders
655 Disorders usually diagnosed in infancy and childhood or adolescence
656 Impulse control disorders
657 Mood disorders
658 Personality disorders
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TABLE A1 (Continued)
Causes of readmission CCS code Diagnosis
659 Schizophrenia and other psychotic disorders
660 Alcohol-related disorders
661 Substance-related disorders
662 Suicide and intentional self-inflicted injury
663 Screening and history of mental health and substance abuse codes
670 Miscellaneous mental health disorders
Hematological/neoplastic 11 Cancer of head and neck
12 Cancer of esophagus
13 Cancer of stomach
14 Cancer of colon
15 Cancer of rectum and anus
16 Cancer of liver and intrahepatic bile ducts
17 Cancer of pancreas
18 Cancer of other gastrointestinal organs, peritoneum
19 Cancer of bronchus, lung
20 Cancer of other respiratory and intrathoracic
21 Cancer of bone and connective tissue
22 Melanoma of skin
23 Other non-epithelial cancer of skin
24 Cancer of breast
25 Cancer of uterus
26 Cancer of cervix
27 Cancer of ovary
28 Cancer of other female genital organs
29 Cancer of prostate
30 Cancer of testis
31 Cancer of other male genital organs
32 Cancer of bladder
33 Cancer of kidney and renal pelvis
34 Cancer of other urinary organs
35 Cancer of brain and nervous system





41 Cancer, other and unspecified primary
42 Secondary malignancies
43 Malignant neoplasm without specification of site
44 Neoplasm of unspecified nature or uncertain behavior
46 Benign neoplasm of uterus
47 Other and unspecified benign neoplasm
59 Deficiency and other anaemias
61 Sickle cell anaemia
62 Coagulation and haemorrhagic disorders
63 Disease of white blood cells
(Continues)
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TABLE A1 (Continued)
Causes of readmission CCS code Diagnosis
64 Other hematologic conditions
Rheumatology problem 54 Gout and other crystal arthropathies
Opthalmology problem 86 Cataract
87 Retinal detachment defects, vascular occlusion and retinopathy
88 Glaucoma
89 Blindness and vision defects
91 Other eye disorders
ENT problem 92 Otitis media and related conditions
93 Conditions associate with dizziness or vertigo
94 Other ear and sense organ disorder
Non-specific chest pain 102 Non-specific chest pain
Oral health problem 136 Disorders of teeth and jaw
137 Diseases of mouth; excluding dental
Obstetric admission including pregnancy 174 Female infertility





181 Other complications of pregnancy
184 Early or threatened labor
185 Prolonged pregnancy
187 Malposition; malpresentation
188 Fetopelvic disproportion; obstruction
189 Previous C-section
190 Fetal distress and abnormal forces of labor
191 Polyhydramnios and other problems of amniotic cavity
192 Umbilical cord complication
193 OB-related trauma to perineum and vulva
194 Forceps delivery
195 Other complications of birth; puerperium affecting management of
mother
196 Other pregnancy and deliver including normal
218 Liveborn
219 Short gestation; low birth weight; and fetal growth retardation
220 Intrauterine hypoxia and birth asphyxia
223 Birth trauma
224 Other perinatal conditions
Dermatology problem 198 Other inflammatory condition of skin
199 Chronic ulcer of skin
200 Other skin disorders
Poisoning 241 Poisoning by psychotrophic agents
242 Poisoning by other medication and drugs
243 Poisoning by nonmedical substances
Syncope 245 Syncope
Other non-cardiac 10 Immunization and screening for infectious disease
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TABLE A1 (Continued)
Causes of readmission CCS code Diagnosis
45 Maintenance chemotherapy, radiotherapy
52 Nutritional deficiencies




121 Other diseases of veins and lymphatics
167 Nonmalignant breast conditions




202 Rheumatoid arthritis and related disease
203 Osteoarthritis
204 Other non-traumatic joint disorders
205 Spondylosis; intervertebral disc disorders; other back problems
206 Osteoporosis
208 Acquired foot deformities
209 Other acquired deformities
210 Systemic lupus erythematosus and connective tissue disorders
211 Other connective tissue disease
212 Other bone disease and musculoskeletal deformities
217 Other congenital anomalies
237 Complication of device; implant or graft
238 Complications of surgical procedure or medical care
240 Burns
246 Fever of unknown origin
247 Lymphadenitis
248 Gangrene
252 Malaise and fatigue
253 Allergic reactions




258 Other screening for suspected conditions (not mental disorders or
infectious disease)
259 Residual codes; unclassified
Heart failure 108 Congestive heart failure non-hypertensive
Arrhythmia 106 Cardiac dysrhythmias
107 Cardiac arrest and ventricular fibrillation
Conduction disorder 105 Conduction disorders
Valve disorders 96 Heart valve disorder
Hyper/hypotension 98 Essential hypertension
99 Hypertension with complications and secondary hypertension
183 Hypertension complicating pregnancy; childbirth and the puerperium
(Continues)
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TABLE A1 (Continued)
Causes of readmission CCS code Diagnosis
249 Shock
Pericarditis 97 Peri-, endo- and myocarditis, cardiomyopathy
Coronary artery disease including angina 101 Coronary atherosclerosis and other heart disease includes angina
Acute myocardial infarction 100 Acute myocardial infarction
Others (cardiac) 103 Pulmonary heart disease
104 Other and ill-defined heart disease
213 Cardiac and circulatory congenital anomalies
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